Skip to main content

Science
Products
Stories
Newsroom
About

Investors Media Careers Partners

Careers
Investors

Changed

Changed

How can we help you?

0 search results for

Suggestions within Pfizer.com

Home
News
Press Releases

Press Release Archive

Press Releases

Year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Month

January

February

March

April

May

June

July

August

September

October

November

December

View 12

View 24

View 48

Categories

Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines

Keywords

All Keywords

Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines

June 2014

06.17.2014
Pfizer Announces Submission of Biologics License Application to the FDA for Investigational Meningococcal B Vaccine
06.11.2014
X-Chem Enters into Multi-Target Collaboration with Pfizer Inc.
- Partnerships
06.11.2014
Pfizer Announces Over 10 Abstracts for XELJANZ® (Tofacitinib Citrate) in Rheumatoid Arthritis to be Presented at the European League Against Rheumatism (EULAR) 2014 Annual Meeting
06.04.2014
KineMed Collaboration with Pfizer Inc. in Diabetes is Extended
- Partnerships
06.04.2014
Pfizer Invites the Public to Listen to Webcast of Pfizer Discussion at Health Care Conference

May 2014

05.29.2014
Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research
05.29.2014
Pfizer and the Avon Foundation for Women Announce $1 Million Grants Program to Address Gaps in Support for People Living with Metastatic Breast Cancer
05.27.2014
Global Investigator Databank expands to five pharmaceutical company members and announces new investigator website
- Partnerships
05.27.2014
Pfizer Brings Frequent Heartburn Relief Over-the-Counter with New Nexium® 24HR
05.26.2014
ANNOUNCEMENT REGARDING ASTRAZENECA PLC
05.23.2014
Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis
05.22.2014
BioRestorative Therapies Signs Research Agreement with Pfizer Inc.
- Partnerships

Page 132
Page 133
Current page 134
Page 135
Page 136

Media Resources & Contact Information

Media Contacts
Press Kits

Anyone may view our press releases, press statements, and press kits.

However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Investors
Media
Careers
Partners

PfizerForAll
Healthcare Professionals
Grant Seekers
Business to Business

Privacy Statement
Accessibility Statement
Terms of Use
Contact Us

Glossary

© 2025 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

Twitter
Facebook
Linked In
Instagram
Youtube